Pharmaceutical Sector

Quality Assurance Manager Rewarded for Whistleblowing

After the pharmaceutical Company GlaxoSmithKline PLC needed to reassess one of their manufacturing plants in Puerto Rico, they sent one of the Company’s quality assurance managers Cheryl Eckard. The former employee of the Company exposed severe abuses such as the production of a skin product for children that was poisonous.

Furthermore, Ms. Eckard observed that drugs often were mixed up in the same bottles in Puerto Rico, a dangerous mistake that has not been corrected.

General: 
Companies: 

Alternative Contraceptives Will Increase Women’s Options

Pharmaceutical Companies are closer to marketing alternative means of birth control. A new contraceptive gel, developed by the Population council Research Centre in conjunction with Antares Pharma, will prevent pregnancy. By applying 3mg every day—to the arms, shoulders, abdomen or legs—women get the same protection as the pull, and with fewer side effects to boot.

General: 
Companies: 

Novartis Meningitis Vaccine Successful in Infants

Novartis AG, a Swiss pharmaceutical company, has released data from a study indicating that the Menveo meningitis vaccine is effective in infants. Bacterial meningitis is a contagious illness that causes an infection of the membrane around the brain and spine. Approximately 50,000 deaths a year result from meningitis. Survivors can experience side effects such as brain damage and learning disabilities.

General: 
Companies: 

Aspirin can Improve Survival Chances in Men Suffering from Prostate Cancer

A study that was recently conducted has shed some light on how men can cheat death, if they are suffering from prostate cancer. It has indicated that those men who’s, prostate cancer has not spread beyond the gland are less likely to die, if they consume aspirin.

General: 

OFT Imposes Fine of £10.2m on Reckitt for Abusing Market Dominance

On Friday, the Office of Fair Trading imposed a fine of £10.2m on pharmaceuticals and domestic products maker Reckitt Benckiser for exploiting its market dominance in association to the National Health Service.

The Company agreed that it ceased supplying its heat burn treatment Gaviscon Original Liquid illegally, in wake of its patent expiry and to encourage the sales of its somewhat same named Gaviscon Advance Liquid, whose patent expiry is due in 2016. As such an activity is prohibited under competition law, so the Company was inflicted with penalty.

General: 
Companies: 

Pages

Subscribe to RSS - Pharmaceutical Sector